Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ruth Weinstock, MD
State University of New York - Upstate Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Marvel Clinical Research
Huntington Beach, California, United States
- Pasadena Clinical Trials
Pasadena, California, United States
- Diabetes Research Center
Tustin, California, United States
- University of Colorado, Barbara Davis Center
Denver, Colorado, United States
- East Coast Institute for Research
Jacksonville, Florida, United States
- University of Miami Diabetes Research Institute
Miami, Florida, United States
- Metabolic Research Institute
West Palm Beach, Florida, United States
- Atlanta Diabetes Associates
Atlanta, Georgia, United States
- East Coast Institute for Research
Canton, Georgia, United States
- Physicians Research Associates, Llc
Lawrenceville, Georgia, United States
- Endocrine Research Solutions, Inc.
Roswell, Georgia, United States
- University of Chicago Kovler Diabetes Center
Chicago, Illinois, United States
- Endeavor Health
Skokie, Illinois, United States
- Indiana Medical Research Institute
Merrillville, Indiana, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Asheville Clinical Research
Asheville, North Carolina, United States
- Unc Endo Clinical Research Unit
Chapel Hill, North Carolina, United States
- Physician'S East
Greenville, North Carolina, United States
- University Hospitals Medical Center
Cleveland, Ohio, United States
- Texas Diabetes & Endocrinology
Austin, Texas, United States
- Tekton Research, Llc
Irving, Texas, United States
- Tekton Research, Llc
McKinney, Texas, United States
- Texas Diabetes % Endocrinology
Round Rock, Texas, United States
- Clinical Trials of Texas
San Antonio, Texas, United States
- Tekton Research, Llc
San Antonio, Texas, United States
- Wasatch Clinical Research, Llc 310
Salt Lake City, Utah, United States
- Virginia Endocrinology Research
Chesapeake, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2024
- Primary completion
- 31 Oct 2025
- Completion
- 31 Dec 2025
- Last update posted
- 19 Aug 2025
- Registered enrollment
- 227
- Registry id
- NCT06238778
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.